Cargando…

Influence of metabolic syndrome components in the course of covid-19 in patients with nonalcoholic fatty liver disease

Detalles Bibliográficos
Autores principales:	Sobirova, Guzal Naimovna, Bafoeva, Zarnigor Orifovna, Karimov, Mirvasit Mirvasikovich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	W.B. Saunders 2022
Materias:	0078
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892283/ http://dx.doi.org/10.1016/j.metabol.2021.155036

Ejemplares similares

Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
por: Golabi, Pegah, et al.
Publicado: (2018)

The Influence of Metabolic Factors for Nonalcoholic Fatty Liver Disease in Women
por: Chung, Goh Eun, et al.
Publicado: (2015)

The metabolic influence of duodenal mucosal resurfacing for nonalcoholic fatty liver disease
por: Chuang, Te-Jung, et al.
Publicado: (2023)

Lipoprotein metabolism in nonalcoholic fatty liver disease
por: Jiang, Zhenghui Gordon, et al.
Publicado: (2013)

Metabolic Targets in Nonalcoholic Fatty Liver Disease
por: Esler, William P., et al.
Publicado: (2019)

Macrophage metabolism in nonalcoholic fatty liver disease
por: Zhang, Wenhui, et al.
Publicado: (2023)

Editorial: Metabolism in nonalcoholic fatty liver disease
por: Najjar, Sonia Michael, et al.
Publicado: (2023)

Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease
por: Karakousis, Nikolaos D., et al.
Publicado: (2022)

Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease
por: Kotlyarov, Stanislav, et al.
Publicado: (2021)

Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease
por: Sharpton, Suzanne R., et al.
Publicado: (2018)

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
por: Pei, Ke, et al.
Publicado: (2020)

Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes
por: Simeone, Jason C, et al.
Publicado: (2017)

Impact of Visceral Fat on the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
por: Jeong, Seul-Ki, et al.
Publicado: (2008)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Time Course of the Development of Nonalcoholic Fatty Liver Disease in the Otsuka Long-Evans Tokushima Fatty Rat
por: Song, Yi-Sun, et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
por: Bhat, Neha, et al.
Publicado: (2023)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease
por: Jiang, Hua, et al.
Publicado: (2023)

The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm
por: Pan, Shuang, et al.
Publicado: (2017)

Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease
por: Machado, M V, et al.
Publicado: (2016)

Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome
por: Lin, Ying-Hsiu, et al.
Publicado: (2018)

Hydrogen inhalation alleviates nonalcoholic fatty liver disease in metabolic syndrome rats
por: Liu, Boyan, et al.
Publicado: (2020)

Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease
por: Lyu, Jingting, et al.
Publicado: (2022)

The correlation between controlled attenuation parameter and metabolic syndrome and its components in middle-aged and elderly nonalcoholic fatty liver disease patients
por: Hu, Yue-Yan, et al.
Publicado: (2018)

From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
por: Kang, Seong Hee, et al.
Publicado: (2021)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Aerobic and Resistance Exercise: Synergistic Influence for Nonalcoholic Fatty Liver Disease
por: Chun, Ho Soo
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals
por: Cordeiro, A., et al.
Publicado: (2015)

The Development of Nonalcoholic Fatty Liver Disease and Metabolic Syndromes in Diet-Induced Rodent Models
por: Aljahdali, Bayan Abdulhafid, et al.
Publicado: (2023)

Incidence of Metabolic Syndrome and Its Risk Factors in Elderly with Nonalcoholic Fatty Liver Disease
por: Lin, Fang-An, et al.
Publicado: (2023)

Diet-induced metabolic hamster model of nonalcoholic fatty liver disease
por: Bhathena, Jasmine, et al.
Publicado: (2011)

Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver
por: Lehmann, Rainer, et al.
Publicado: (2013)

Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
por: Zhao, Li, et al.
Publicado: (2017)

The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease
por: Seo, Ji-Yeon, et al.
Publicado: (2021)

Association of Metabolic Signatures with Nonalcoholic Fatty Liver Disease in Pediatric Population
por: Chae, Woori, et al.
Publicado: (2022)

Novel metabolic phenotypes for extrahepatic complication of nonalcoholic fatty liver disease
por: Yi, Jiayi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_su47ud2t2vu6710kaqhr6n6mkr